163 related articles for article (PubMed ID: 25295086)
1. Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report.
Ito K; Asano T; Tominaga S; Yoshii H; Sawazaki H; Asano T
Oncol Lett; 2014 Nov; 8(5):2032-2036. PubMed ID: 25295086
[TBL] [Abstract][Full Text] [Related]
2. Sarcomatoid renal cell carcinoma with autosomal dominant polycystic kidney disease: a case report and literature review.
Hakozaki Y; Uchiyama K; Yanai A; Yamada D; Kamijo Y; Ishibashi Y
CEN Case Rep; 2021 May; 10(2):199-207. PubMed ID: 33064294
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin in polycystic kidneys.
Eckardt KU; Möllmann M; Neumann R; Brunkhorst R; Burger HU; Lonnemann G; Scholz H; Keusch G; Buchholz B; Frei U
J Clin Invest; 1989 Oct; 84(4):1160-6. PubMed ID: 2794053
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin concentration in cyst fluid in patients with simple renal cysts.
Franek E; Kokot F; Wiecek A; Pawłowski W; Myrta J; Szewczyk W; Bar A
Nephron; 1994; 67(4):431-5. PubMed ID: 7969676
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved.
Ross RP; McCrea JB; Besarab A
ASAIO J; 1994; 40(3):M880-5. PubMed ID: 8555638
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-producing renal cell carcinoma in chronic hemodialysis patients: a report of two cases.
Sakamoto S; Igarashi T; Osumi N; Imamoto T; Tobe T; Kamiya M; Ito H
Int J Urol; 2003 Jan; 10(1):49-51. PubMed ID: 12534927
[TBL] [Abstract][Full Text] [Related]
7. Impact of increased erythropoietin receptor expression and elevated serum erythropoietin levels on clinicopathological features and prognosis in renal cell carcinoma.
Ito K; Yoshii H; Asano T; Horiguchi A; Sumitomo M; Hayakawa M; Asano T
Exp Ther Med; 2012 Jun; 3(6):937-944. PubMed ID: 22969996
[TBL] [Abstract][Full Text] [Related]
8. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
9. Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.
Góes MA; Dalboni MA; Manfredi SR; Cendoroglo MS; Batista MC; Canziani ME; Balakrishnan VS; Pereira BJ; Draibe SA; Cendoroglo M
Clin Nephrol; 2010 Jan; 73(1):7-13. PubMed ID: 20040346
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-producing renal cell carcinoma arising from autosomal dominant polycystic kidney disease.
Hama Y; Kaji T; Ito K; Hayakawa M; Tobe M; Kosuda S
Br J Radiol; 2005 Mar; 78(927):269-71. PubMed ID: 15730996
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia.
Wiesener MS; Münchenhagen P; Gläser M; Sobottka BA; Knaup KX; Jozefowski K; Jürgensen JS; Roigas J; Warnecke C; Gröne HJ; Maxwell PH; Willam C; Eckardt KU
Int J Cancer; 2007 Dec; 121(11):2434-42. PubMed ID: 17640059
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin-induced secondary polycythemia in a patient with a renal cell carcinoma. A case report.
Nielsen OJ; Jespersen FF; Hilden M
APMIS; 1988 Aug; 96(8):688-94. PubMed ID: 3046641
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia Secondary to Renal Hemangioblastoma: A Case Report and Literature Review.
Lee Y; Cheng SM; Hwang DY; Chiu YL; Chou YH
Int J Surg Pathol; 2024 Feb; 32(1):140-144. PubMed ID: 37150964
[TBL] [Abstract][Full Text] [Related]
15. Renal hemodynamic response to erythropoietin-induced polycythemia in 5/6 nephrectomised rats is different from normal rats.
Paixão AD; Ferreira AT; Oshiro ME; Razvickas CV; Boim MA; Schor N
Exp Nephrol; 1998; 6(3):245-52. PubMed ID: 9639040
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-producing renal cell carcinoma arising from acquired cystic disease of the kidney.
Hanada T; Mimata H; Ohno H; Nasu N; Nakagawa M; Nomura Y
Int J Urol; 1998 Sep; 5(5):493-4; discussion 495. PubMed ID: 9781442
[TBL] [Abstract][Full Text] [Related]
17. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
Shih LY; Huang JY
Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic Membranous Glomerulonephritis Leading to Secondary Polycythemia: A Rare Association.
Yadav P; Pathak S; Malik MS
Cureus; 2023 Jan; 15(1):e33985. PubMed ID: 36811053
[TBL] [Abstract][Full Text] [Related]
20. Multifocal renal cell carcinoma of different histological subtypes in autosomal dominant polycystic kidney disease.
Na KY; Kim HS; Park YK; Chang SG; Kim YW
Korean J Pathol; 2012 Aug; 46(4):382-6. PubMed ID: 23110033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
